SCYX · Scynexis Inc
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $19.22M | $20.6M | $3.75M | $140.14M | $5.09M | $13.16M | $0 | $121K | $257K | $257K | $257K | $257K | $1.26M | $16.86M | |
| $14.72M | — | — | — | — | — | — | — | — | — | — | — | $15.45M | $16.31M | |
| $2.9M | — | — | — | — | — | — | — | — | — | — | — | $3.58M | $552K | |
| — | — | — | — | — | — | — | — | — | — | — | — | 284.87% | 3.27% | |
| $26.24M | $22.28M | $26.41M | $30.93M | $27.26M | $23.77M | $36.52M | $38.39M | $21.56M | $18.33M | $20.08M | $16.44M | $8.29M | $4.36M | |
| $15.59M | $14.4M | $14.46M | $20.92M | $62.96M | $49.92M | $14.63M | $10.65M | $8.68M | $8.25M | $8M | $12.17M | $7.62M | $4.38M | |
| — | — | — | $400K | $700K | $200K | — | — | — | — | — | — | — | — | |
| — | — | $0 | $580K | $606K | $379K | $111K | — | — | — | — | — | — | — | |
| $41.83M | $36.68M | $40.86M | $67.47M | $90.85M | $74M | $51.15M | $49.04M | $30.24M | $26.58M | $28.07M | $28.61M | $15.9M | $7.76M | |
| -$22.62M | -$16.07M | -$37.12M | $72.67M | -$85.76M | -$60.84M | -$51.15M | -$48.92M | -$29.98M | -$26.32M | -$27.82M | -$28.35M | -$14.65M | -$7.2M | |
| — | -78.03% | -990.84% | 51.85% | -1684.48% | -462.19% | — | -40430.58% | -11666.54% | -10241.25% | -10823.74% | -11030.74% | -1166.16% | -42.74% | |
| — | — | -$37.12M | $73.25M | -$85.15M | -$60.46M | -$51.04M | — | — | — | — | — | — | — | |
| $0 | $173K | $828K | $3.13M | $5.2M | $2.66M | $1.18M | $986K | $1.63M | $1.46M | $351K | -$11K | $48K | — | |
| $12.38M | $7.47M | $15.98M | -$5.49M | $18.25M | $24.88M | -$7.18M | -$4.79M | $10.78M | $1.26M | -$2.17M | $11K | $7.88M | -$23.26M | |
| — | -$8.61M | -$21.14M | $67.18M | -$67.51M | -$35.95M | -$58.33M | -$53.71M | -$19.2M | -$25.06M | -$30M | -$28.34M | -$6.77M | -$31.91M | |
| — | $0 | $151K | $138K | -$4.7M | -$3.09M | -$3.15M | $0 | -$6.74M | $0 | $0 | $0 | -$1.17M | $0 | |
| -$10.24M | -$8.61M | -$21.29M | $67.04M | -$62.81M | -$32.87M | -$55.19M | -$53.71M | -$12.47M | -$25.06M | -$29.99M | -$32.62M | -$4.23M | -$30.46M | |
| — | -41.79% | -568.29% | 47.84% | -1233.73% | -249.68% | — | -44388.43% | -4851.36% | -9750.97% | -11668.87% | -12693.77% | -337.1% | -180.7% | |
| — | — | — | — | — | — | — | — | — | — | -$29.99M | -$32.62M | -$5.87M | -$46.81M | |
| USD/shares | -$2.10 | -$1.36 | -$3.52 | $11.20 | -$11.76 | -$10.00 | — | — | — | — | -$126.40 | -$214.40 | -$83.20 | -$11,157.60 |
| USD/shares | -$2.10 | -$1.36 | -$3.52 | $11.12 | -$11.76 | -$10.00 | — | — | — | — | -$126.40 | -$214.40 | -$215.20 | -$11,157.60 |
| shares | — | 6.24M | 6.06M | 5.98M | 5.33M | 3.3M | 1.34M | 701.02K | 548.55K | 334.33K | 237.94K | 152.04K | 70.79K | 4195.15 |
| shares | — | 6.24M | 6.06M | 6.05M | 5.33M | 3.3M | 1.34M | 701.02K | 548.55K | 334.33K | 237.94K | 152.04K | 74.21K | 4195.15 |
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 38 similar-size Drug Manufacturers - Specialty & Generic companies (of 95 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| License And Service | $19,157,000 | $3,746,000 | $139,097,000 | $103,000 | $12,050,000 | $0 |
| Product | $1,444,000 | $0 | $1,044,000 | $4,988,000 | $1,113,000 | $0 |